WANG Liqun(Richard


                   CEO Fosun Kite Biotechnology Co. Ltd.


加入复星凯特前,王立群博士在西比 曼生物科技担任首席运营官,全面管理公司运营、细胞治疗产品的生产、药理和临床研 究,并兼任干细胞事业部总经理。

Having spent close to 20 years in R&D and management positions in both multinational and Chinese biopharmaceutical companies, he has taken senior roles with increasing leadership responsibilities in Procter & Gamble Pharmaceutical, Bristol-Myers Squibb in the US, AstraZeneca Innovation Center and GSK R&D Center in China. 

Prior to Fosun Kite, Richard was the Chief Operation Officer of Cellular Biomedicine Group, where he was in charge of the company’s cell therapy pipeline including manufacturing, clinical development and registration. He was also the GM for the stem cell therapy business unit of the company.